Table I.
Clinical manifestation and imaging findings of the cases examined.
| Characteristic | FM | MM/NM |
|---|---|---|
| Age (years) | ||
| Median | 55 | 56 |
| Range | 26–69 | 44–68 |
| TNM | ||
| IIA | 17 | 0 |
| IIB | 6 | 2 |
| IIIA | 1 | 6 |
| IIIB | 1 | 1 |
| IIIC | 1 | 1 |
| ADC (×10−3 mm2/s) | ||
| Before NAC | ||
| Average | 0.833 | 0.815 |
| SD | 0.153 | 0.146 |
| After NAC | ||
| Average | 0.963 | 1.137 |
| SD | 0.216 | 0.245 |
| Change in ADC (%) | ||
| Average | 17 | 50.1 |
| SD | 23.6 | 58.9 |
| Size in MRI (mm2) | ||
| Before NAC | ||
| Average | 531.1 | 2,088 |
| SD | 524.4 | 1,583 |
| After NAC | ||
| Average | 288.4 | 1,376.2 |
| SD | 277.2 | 1,048 |
| Response rate (%) | ||
| Average | 44.5 | 34.2 |
| SD | 27.7 | 17.6 |
FM, focal mass; MM/NM, multiple masses and/or non-mass; ADC, apparent diffusion coefficient; TNM, tumor-node-metastases classification and SD, standard deviation.